Experts To Industry: Start Implementing Social Media Guidelines Now
This article was originally published in The Gray Sheet
Executive Summary
While FDA’s oversight and expectations for device makers using social media is still hazy, two experts advise companies to put together policies outlining their interpretation of new agency guidances on the topic and how they plan to comply.
You may also be interested in...
Critics Call FDA Third-Party Social Media Guidance ‘Overbroad’
Some stakeholders are concerned the agency’s draft guidance is overreaching and could have a chilling effect. AdvaMed recommends FDA consider splitting the guidance into product-specific documents to reference regulations that may apply to industries differently.
FDA Twitter Guidance Lacks Flexibility, And May Be Unconstitutional, Critics Say
Stakeholders say the agency’s communication requirements for space-limited online platforms are too restricting and violate the First Amendment. Many of them are calling on the agency to withdraw the guidance and try again. The device industry has a comparatively toned down response so far, but wants more flexibility.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.